Xilio Therapeutics (XLO) Interest Coverage Ratio (2020 - 2022)

Xilio Therapeutics has disclosed Interest Coverage Ratio across 3 years of filings, most recently posting 164.53 for Q1 2022.

• In Q1 2022, Interest Coverage Ratio fell 46.4% year-over-year to 164.53; the TTM figure through Mar 2022 stood at 107.77 (changed N/A YoY), while the FY2021 annual figure was 99.26, down 19.34% from the prior year.
• Interest Coverage Ratio came in at 164.53 for Q1 2022 at Xilio Therapeutics, down from 112.39 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 55.04 in Q3 2021 to a low of 164.53 in Q1 2022.
• Average Interest Coverage Ratio over 3 years is 105.88, with a median of 112.39 recorded in 2021.
• Year-over-year, Interest Coverage Ratio increased 26.23% in 2021 and plunged 46.4% in 2022.
• Over 3 years, Interest Coverage Ratio stood at 116.36 in 2020, then gained by 3.41% to 112.39 in 2021, then sank by 46.39% to 164.53 in 2022.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 164.53 in Q1 2022, 112.39 in Q4 2021, and 55.04 in Q3 2021.